Clinical Trials Logo

Clinical Trial Summary

Low-dose haloperidol is known to be effective for the treatment of postoperative nausea and vomiting (PONV). However, precise dose-response studies have not been completed, especially in patients at high risk for PONV who require combination therapy. This study sought to identify the optimal dose of haloperidol that could be combined with dexamethasone without adverse effects in high-risk PONV patients receiving intravenous patient-controlled anesthesia (IV PCA) after gynecological laparoscopic surgery.


Clinical Trial Description

Female adults with three established PONV risk factors based on Apfel's score were randomised into one of three study groups. At the end of anaesthesia, groups H0, H1, and H2 were given intravenous (IV) saline, haloperidol 1 mg, and haloperidol 2 mg, respectively. All patients were given dexamethasone during the induction of anaesthesia. The overall early (0-2 h) and late (2-24 h) incidences of nausea, vomiting, rescue anti-emetic administration, pain, and adverse effects (cardiac arrhythmias and extrapyramidal effects) were assessed postoperatively. The sedation score was recorded in the postanaesthesia care unit (PACU). ;


Study Design


Related Conditions & MeSH terms


NCT number NCT01639599
Study type Interventional
Source The Catholic University of Korea
Contact
Status Completed
Phase N/A
Start date March 2012
Completion date May 2013

See also
  Status Clinical Trial Phase
Completed NCT01437462 - Sevoflurane, Propofol, Postoperative Pain Phase 4
Recruiting NCT05401058 - Low-dose Droperidol for Prevention of Postoperative Delirium in Elderly Patients After Non-cardiac Surgery N/A
Completed NCT05687227 - Online Education and Counseling Regarding Gynecological Examination N/A
Recruiting NCT05276882 - Improved Rehabilitation After Surgery and Hypnosis: Benefits Potentiated by a Preoperative Consultation N/A